Porter James Richard 4
4 · Nuvalent, Inc. · Filed Mar 10, 2026
Research Summary
AI-generated summary of this filing
Nuvalent (NUVL) CEO James R. Porter Exercises Options, Sells Shares
What Happened James R. Porter (President, CEO and Director) exercised options on March 6, 2026 to acquire 30,000 shares at $27.85 each (cost $835,500). On the same day he sold a total of 30,000 shares in three open‑market transactions for combined proceeds of $2,969,550: 13,585 shares (weighted avg $98.59) for $1,339,345; 16,015 shares (weighted avg $99.29) for $1,590,129; and 400 shares (weighted avg $100.19) for $40,076. The filing also shows a separate derivative conversion/disposition of 30,000 shares at $0 under code M (reflecting option exercise mechanics).
Key Details
- Transaction date: March 6, 2026. Form 4 filed March 10, 2026 (timely filing).
- Exercise: 30,000 shares @ $27.85 — $835,500 total cash cost.
- Sales (weighted averages / ranges):
- 13,585 shares @ $98.59 (prices ranged $98.03–$99.01) — $1,339,345 (F2).
- 16,015 shares @ $99.29 (prices ranged $99.03–$100.02) — $1,590,129 (F3).
- 400 shares @ $100.19 (prices ranged $100.12–$100.25) — $40,076 (F4).
- Total sales proceeds: $2,969,550.
- The reporting person used a Rule 10b5‑1 trading plan adopted Dec 4, 2025 (F1).
- Vesting note: the underlying option shares vest monthly over four years from Jan 6, 2023 (F5).
- Shares owned after the transactions are not specified in the provided excerpt — see the full Form 4 for post‑transaction holdings.
Context This sequence — exercising options and selling an equivalent number of shares on the same day — is commonly a cash‑raising/cashless exercise pattern. The transactions were carried out under a pre‑arranged 10b5‑1 plan, which generally means the sales were scheduled in advance and may not reflect contemporaneous views on the stock. The separate $0 disposal line reflects the option conversion mechanics; consult the full filing for complete mechanics and ownership totals.
Insider Transaction Report
- Exercise/Conversion
Class A Common Stock
[F1]2026-03-06$27.85/sh+30,000$835,500→ 354,879 total - Sale
Class A Common Stock
[F1][F2]2026-03-06$98.59/sh−13,585$1,339,345→ 341,294 total - Sale
Class A Common Stock
[F1][F3]2026-03-06$99.29/sh−16,015$1,590,129→ 325,279 total - Sale
Class A Common Stock
[F1][F4]2026-03-06$100.19/sh−400$40,076→ 324,879 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F5]2026-03-06−30,000→ 147,780 totalExercise: $27.85Exp: 2033-01-06→ Class A Common Stock (30,000 underlying)
Footnotes (5)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2025.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.03 to $99.01, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) of this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.03 to $100.02, inclusive.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.12 to $100.25, inclusive.
- [F5]The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.